About NextBio
NextBio is a Healthcare company based in Santa Clara (United States) founded in 2004, and was acquired by Illumina in October 2013. NextBio provides a platform to aggregate and interpret large quantities of genomic data for research and clinical applications. NextBio has raised $28.35 million across 10 funding rounds from investors including Illumina, NIH and HHS. The company was acqui-hired. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery. Its competitors include DNAnexus, Helix and Cytel; 3 of its 3 listed competitors have raised funding.
Company details
NextBio was founded in 2004 in Santa Clara, United States, as a software company in the life sciences sector. An ontology-based semantic framework is provided through its platform, connecting heterogeneous genomic data and textual information based on gene, tissue, disease, and compound ontologies. The platform supports searching, discovering, and sharing knowledge for researchers and clinicians in RD and drug development at pharmaceutical companies. It has been acquired by Illumina.
- Headquarters Santa Clara, United States
- Stage Acquired
- SectorsHealthcare
- Website nextbio.com
- Social LinkedIn X
- Acquired by Illumina (Oct 2013)
Funding Insights of NextBio
NextBio has successfully raised a total of $28.35M across 10 strategic funding rounds. The most recent funding activity was a Grant round of $1.19 million completed in July 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $28.35M
- Total Rounds 10
- Last Round Grant — $1.19M
- First Round $1.1M
(Feb 2005)
- Investors Count 3
All 10 funding rounds of NextBio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2010 | $1.19M | Grant | – | – | |
| Sep 2009 | $8M | Series C | – | Rising Tide Fund | – |
| Jun 2009 | $6.76M | Series C | – | – | – |
| Apr 2009 | $978,982 | Grant | – | – | |
| Mar 2009 | $1.19M | Grant | – | – | |
| Jan 2009 | $4.71M | Series C | – | – | – |
| Jun 2007 | $7M | Series B | – | Rising Tide Fund | – |
| Jan 2007 | $780,000 | Series B | – | – | – |
| Jun 2006 | $157,299 | Grant | – | – | |
| Feb 2005 | $1.1M | Series A | – | – | – |
4 investors in total: 4 institutional.
Investors in NextBio
NextBio has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Illumina, NIH and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
US focused stage-agnostic venture capital firm | rtf.vc | San Francisco, United States | ||
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States | |
Developer of technologies for analysis of genetic variation and function | 1993 | illumina.com | San Diego, United States |
Investor details for NextBio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of NextBio
4 dated milestones of NextBio across 9 years, from founding to its latest funding, stage changes and deals.
- Founded NextBio is founded.
- Funding First funding round of $1.1M.
- Funding Latest funding round, Grant, of $1.2M.
- Exit Acquired by Illumina.
Competitors of NextBio
NextBio has 3 listed competitors in our database, 3 of them funded. They include DNAnexus, Helix and Cytel.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| dnanexus.com | 2009 | Mountain View, United States | $472.55M | 143 | Cloud-based genome informatics and data management are provided. | |
| helix.com | 2015 | San Francisco, United States | $435M | Genomic database for clinical research is provided. | ||
| cytel.com | 1987 | Cambridge, United States | $2M | 509 | Data analysis and statistical solutions are provided for life sciences. |
Detailed competitors of NextBio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of NextBio
Websites that share an audience with NextBio (nextbio.com).
Websites whose visitors overlap most with NextBio. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
cbioportal.org | cbioportal.org | 100% | #254,424 | – | |
vadlo.com | vadlo.com | 98% | #7,173,362 | – | |
massgenomics.org | massgenomics.org | 91% | #8,635,404 | – | |
illuminakk.co.jp | illuminakk.co.jp | 84% | #10,034,310 | – | |
chembank.broadinstitute.org | chembank.broadinstitute.org | 82% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 16 similar websites and full traffic analytics for NextBio
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 16 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as NextBio (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nextbio
Complete news archive for NextBio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NextBio
NextBio was founded in 2004 and raised its 1st funding round 1 year after it was founded.
NextBio is headquartered in Santa Clara, United States. It is registered at Santa Clara, California, United States.
NextBio is a funded company, having raised a total of $28.35M across 10 funding rounds to date. The company's 1st funding round was a Series A of $1.1M, raised on Feb 2005.
NextBio was founded in 2004 in Santa Clara, United States, as a software company in the life sciences sector. An ontology-based semantic framework is provided through its platform, connecting heterogeneous genomic data and textual information based on gene, tissue, disease, and compound ontologies. The platform supports searching, discovering, and sharing knowledge for researchers and clinicians in RD and drug development at pharmaceutical companies. It has been acquired by Illumina.
NextBio has 4 investors. Key investors include Illumina, NIH, HHS, and Rising Tide Fund.
Yes. NextBio was acquired by Illumina in October 2013.